There have been substantial advances in the understanding of the basic biology and pathogenesis of malignant glioma and medulloblastoma over the past two decades. This Review summarizes these developments in the context of the molecular classification of these types of brain cancer and discusses the implications for the design of new treatment regimens.
- Jason T. Huse
- Eric C. Holland